2024
Discharge Information About Adverse Drug Reactions Indicates Lower Self-Reported Adverse Drug Reactions and Fewer Concerns in Patients After Percutaneous Coronary Intervention
Pettersen T, Schjøtt J, Allore H, Bendz B, Borregaard B, Fridlund B, Hadjistavropoulos H, Larsen A, Nordrehaug J, Rasmussen T, Rotevatn S, Valaker I, Wentzel-Larsen T, Norekvål T, Investigators C. Discharge Information About Adverse Drug Reactions Indicates Lower Self-Reported Adverse Drug Reactions and Fewer Concerns in Patients After Percutaneous Coronary Intervention. Heart Lung And Circulation 2024, 33: 350-361. PMID: 38238118, DOI: 10.1016/j.hlc.2023.12.005.Peer-Reviewed Original ResearchSelf-reported adverse drug reactionsPrescribed pharmacotherapyPotential adverse drug reactionsAdverse drug reactionsPercutaneous coronary interventionPatient-reported outcome measuresCovariate-adjusted logistic regressionConfidence intervalsNational quality registryProspective multicentre cohort studyAssociated with incidencePatients' medical recordsIntervention aimHealthcare providersQuality registryMulticentre cohort studyDischarge informationDrug reactionsInformation patientsOdds ratioOutcome measuresCohort studyHospital dischargeLogistic regressionPCI centre
2022
Digital phenotyping by wearable-driven artificial intelligence in older adults and people with Parkinson’s disease: Protocol of the mixed method, cyclic ActiveAgeing study
Torrado JC, Husebo BS, Allore HG, Erdal A, Fæø SE, Reithe H, Førsund E, Tzoulis C, Patrascu M. Digital phenotyping by wearable-driven artificial intelligence in older adults and people with Parkinson’s disease: Protocol of the mixed method, cyclic ActiveAgeing study. PLOS ONE 2022, 17: e0275747. PMID: 36240173, PMCID: PMC9565381, DOI: 10.1371/journal.pone.0275747.Peer-Reviewed Original ResearchConceptsREM Sleep Behavior Disorder Screening QuestionnaireUnified Parkinson's Disease Rating ScaleDisease Rating ScaleGeriatric Depression ScaleApathy Evaluation ScaleParkinson's diseaseOlder adultsGeriatric Anxiety InventoryParkinson's Disease Rating ScaleClinical assessment scalesMontreal Cognitive AssessmentNew outcome measureQuality of lifeGlobal public healthHealthy older adultsClinical trialsOutcome measuresDepression ScaleLifestyle changesScreening QuestionnaireWaiting listFunctional limitationsSymptom evolutionNeurological disordersAssessment Scale